Interplay among viral antigens, cellular pathways and tumor microenvironment in the pathogenesis of EBV-driven lymphomas.

scientific article published on 03 August 2013

Interplay among viral antigens, cellular pathways and tumor microenvironment in the pathogenesis of EBV-driven lymphomas. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.SEMCANCER.2013.07.005
P698PubMed publication ID23917255

P50authorRiccardo DolcettiQ37378489
Jessica Dal ColQ59145519
Antonino CarboneQ61134450
Debora MartorelliQ114435428
P2093author name stringEva Klein
P2860cites workDistinct types of diffuse large B-cell lymphoma identified by gene expression profilingQ27860529
P433issue6
P921main subjectpathogenesisQ372016
P304page(s)441-456
P577publication date2013-08-03
P1433published inSeminars in Cancer BiologyQ1908668
P1476titleInterplay among viral antigens, cellular pathways and tumor microenvironment in the pathogenesis of EBV-driven lymphomas
P478volume23

Reverse relations

cites work (P2860)
Q38907078A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.
Q39188257BZLF1 Attenuates Transmission of Inflammatory Paracrine Senescence in Epstein-Barr Virus-Infected Cells by Downregulating Tumor Necrosis Factor Alpha
Q38877813Both high and low levels of cellular Epstein-Barr virus DNA in blood identify failure after hematologic stem cell transplantation in conjunction with acute GVHD and type of conditioning
Q36651583Clonality Analysis of Immunoglobulin Gene Rearrangement by Next-Generation Sequencing in Endemic Burkitt Lymphoma Suggests Antigen Drive Activation of BCR as Opposed to Sporadic Burkitt Lymphoma.
Q28077209Co-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesis
Q33846801Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy.
Q35808018Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma
Q54221806EBV Positive Diffuse Large B Cell Lymphoma and Chronic Lymphocytic Leukemia Patients Exhibit Increased Anti-dUTPase Antibodies.
Q41168739EBV, an inhibited receptor kinase, and lymphoma
Q51735191EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts.
Q37619108Epstein-Barr virus and telomerase: from cell immortalization to therapy
Q39036600Epstein-Barr virus infection induces miR-21 in terminally differentiated malignant B cells
Q52719942Extra-telomeric functions of telomerase in the pathogenesis of Epstein-Barr virus-driven B-cell malignancies and potential therapeutic implications.
Q40291554Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma
Q34671009HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscape
Q89899110Identification and cloning of a new western Epstein-Barr virus strain that replicates efficiently in primary B cells
Q91315039Identification of the Epstein Barr Virus portal
Q47148419Impact of Chronic Viral Infection on T-Cell Dependent Humoral Immune Response
Q40056807Lytic EBV infection investigated by detection of Soluble Epstein-Barr virus ZEBRA in the serum of patients with PTLD.
Q39281253Multiple viral infections in primary effusion lymphoma: a model of viral cooperation in lymphomagenesis.
Q49590083Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor.
Q38568602Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma
Q40089376Regulation of Telomere Homeostasis during Epstein-Barr virus Infection and Immortalization.
Q57176933Role of Epstein-Barr Virus in the Pathogenesis of Head and Neck Cancers and Its Potential as an Immunotherapeutic Target
Q37603448Short-term inhibition of TERT induces telomere length-independent cell cycle arrest and apoptotic response in EBV-immortalized and transformed B cells
Q59355991The interplay between local immune response and Epstein-Barr virus-infected tonsillar cells could lead to viral infection control
Q38212485Xenogeneic therapeutic cancer vaccines as breakers of immune tolerance for clinical application: to use or not to use?

Search more.